Learn More
- Evaluate inhibitory effect of aspirin on platelet aggregation
- Lyophilized preparation of sodium arachidonate
- Lyophilization enables long term storage and stability
- Screen or confirm ASA use
- Working concentration: 5mg/mL (500μg/mL)
- Final concentration: 0.05g/mL (50μg/mL)
Specifications
Concentration
5 mg/mL
Type
Arachidonic Acid
For Use With (Application)
Routine platelet aggregation studies for in-vitro use, differential diagnosis of Aspirin-like release defects and storage pool disease, to evaluate the inhibitory effect of Aspirin on platelet aggregation
Quantity
3 x 0.5 mL
Form
Lyophilized
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.